Xiaohua H. Hu
Nanning, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Surgical Outcomes of Perioperative Toripalimab in Stage III Resectable Non-Small Cell Lung Cancer: Post Hoc Analysis of the Neotorch Randomized Clinical Trial.
Journal: JAMA surgery
Published: July 15, 2026
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): final analysis of a randomised, open-label, international, phase 3 study.
Journal: The Lancet. Oncology
Published: May 30, 2025
Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation.
Journal: Signal transduction and targeted therapy
Published: January 18, 2025
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non-Small Cell Lung Cancer: The Neotorch Randomized Clinical Trial.
Journal: JAMA
Published: January 16, 2024
SALIRI-based (raltitrexed plus irinotecan) therapy as a second-line treatment for patients with metastatic colorectal cancer (SALLY): A prospective, multicenter, non-interventional, registry study.
Journal: Cancer communications (London, England)
Published: November 17, 2023
An Explainable Framework for Predicting Drug-Side Effect Associations via Meta-Path-Based Feature Learning in Heterogeneous Information Network.
Journal: IEEE/ACM transactions on computational biology and bioinformatics
Published: August 24, 2023
Concurrent chemoradiotherapy plus anlotinib vs. concurrent chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma: An interim analysis of a multicenter randomized controlled trial.
Journal: Oncology letters
Published: March 30, 2023
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.
Journal: Lancet (London, England)
Published: January 17, 2023
AutoMSR: Auto Molecular Structure Representation Learning for Multi-label Metabolic Pathway Prediction.
Journal: IEEE/ACM transactions on computational biology and bioinformatics
Published: August 22, 2022
Maintenance therapy improves the survival outcomes of patients with metastatic nasopharyngeal carcinoma responding to first-line chemotherapy: a multicentre, randomized controlled clinical study.
Journal: Journal of cancer research and clinical oncology
Published: June 16, 2022
Treatment strategy, overall survival and associated risk factors among patients with unresectable stage IIIB/IV non-small cell lung cancer in China (2015-2017): A multicentre prospective study.
Journal: The Lancet regional health. Western Pacific
Published: April 25, 2022
A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer.
Journal: Therapeutic advances in medical oncology
Published: December 21, 2021
Last Updated: 09/26/2026